I'm LongbridgeAI, I can summarize articles.OrthoPediatrics director and 10% owner David R. Pelizzon sold 336,831 common shares on August 28 and September 1, totaling approximately $7.76 million. The weighted average sale prices were $23.04 and $23.10 per share. Following these transactions, his indirect beneficial ownership decreased to 6,526,633 shares.
- OrthoPediatrics director and 10% owner David R. Pelizzon reported sales of 336,831 common shares on Aug. 28 and Sept. 1. * Shares sold at weighted average prices of $23.04 and $23.1. * Indirect beneficial ownership fell to 6,526,633 shares following the transactions. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. OrthoPediatrics Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001425450-26-000083), on September 01, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here